• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

突破障碍:加强医院对镰状细胞病管理的支持。

Breaking barriers: Enhancing hospital support for sickle cell disease management.

作者信息

Elenga Narcisse, Fahem Abdelaziz

机构信息

Paediatric Department, Centre Hospitalier de Cayenne, French Guiana.

Hemara Bio, Dubai, UAE.

出版信息

J Public Health Res. 2025 Jul 21;14(3):22799036251356775. doi: 10.1177/22799036251356775. eCollection 2025 Jul.

DOI:10.1177/22799036251356775
PMID:40697490
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12280255/
Abstract

BACKGROUND

Sickle cell disease (SCD) management requires comprehensive care coordination and specialised resources, particularly in endemic regions. We describe the implementation and outcomes of a unique model, the Integrated Centre for Sickle Cell Disease (CID), in French Guiana, a region with high SCD prevalence.

DESIGN AND METHODS

We established a comprehensive SCD care centre incorporating dedicated clinical space, specialised staff, and integrated emergency services. The model included 24/7 specialist availability, priority admission protocols, and a day hospital facility for managing acute complications.

RESULTS

The CID currently serves 740 patients (280 children, 406 adults, including 23 elderly patients aged 60-72 years). In 2022, the centre documented 4673 patient visits, comprising 2209 consultations and 417-day hospitalisations. Of these day hospitalisations, 229 were for vaso-occlusive crises, 147 for erythropheresis, 13 for therapeutic bleeding, and 28 for plasmaphaeresis. Most notably, following CID's establishment, emergency room deaths were eliminated, compared to 2-3 annual deaths previously reported due to acute splenic sequestration. The centre maintained this achievement over eight consecutive years.

CONCLUSIONS

The CID model demonstrates successful implementation of comprehensive SCD care in a resource-limited setting. The complete elimination of emergency room deaths over 8 years, along with improved patient retention and follow-up, suggests that this model could serve as a template for other regions with high SCD prevalence. The success of this approach highlights the importance of integrated, specialised care in managing SCD effectively.

摘要

背景

镰状细胞病(SCD)的管理需要全面的护理协调和专业资源,尤其是在流行地区。我们描述了在法属圭亚那一个SCD患病率很高的地区,一种独特模式——镰状细胞病综合中心(CID)的实施情况和成果。

设计与方法

我们建立了一个综合性的SCD护理中心,包括专门的临床空间、专业人员和综合急诊服务。该模式包括全天候的专家服务、优先入院协议以及一个用于管理急性并发症的日间医院设施。

结果

CID目前为740名患者提供服务(280名儿童,406名成人,包括23名60 - 72岁的老年患者)。2022年,该中心记录了4673次患者就诊,包括2209次门诊和417次日间住院。在这些日间住院中,229次是因为血管闭塞性危机,147次是因为红细胞单采,13次是因为治疗性出血,28次是因为血浆置换。最值得注意的是,与之前每年因急性脾梗死报告的2 - 3例死亡相比,CID成立后,急诊室死亡情况得以消除。该中心连续八年保持了这一成果。

结论

CID模式表明在资源有限的环境中成功实施了全面的SCD护理。8年来急诊室死亡情况完全消除,同时患者留存率和随访情况得到改善,这表明该模式可以作为其他SCD高流行地区的模板。这种方法的成功凸显了综合、专业护理在有效管理SCD方面的重要性。

相似文献

1
Breaking barriers: Enhancing hospital support for sickle cell disease management.突破障碍:加强医院对镰状细胞病管理的支持。
J Public Health Res. 2025 Jul 21;14(3):22799036251356775. doi: 10.1177/22799036251356775. eCollection 2025 Jul.
2
Sickle Cell Disease镰状细胞病
3
Folate supplementation in people with sickle cell disease.镰状细胞病患者的叶酸补充
Cochrane Database Syst Rev. 2018 Mar 16;3(3):CD011130. doi: 10.1002/14651858.CD011130.pub3.
4
Inhaled nitric oxide for treating pain crises in people with sickle cell disease.吸入一氧化氮治疗镰状细胞病患者的疼痛危象。
Cochrane Database Syst Rev. 2022 Jul 8;7(7):CD011808. doi: 10.1002/14651858.CD011808.pub3.
5
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2017 Jul 3;7(7):CD012380. doi: 10.1002/14651858.CD012380.pub2.
6
Interventions for chronic kidney disease in people with sickle cell disease.镰状细胞病患者慢性肾脏病的干预措施。
Cochrane Database Syst Rev. 2023 Aug 4;8(8):CD012380. doi: 10.1002/14651858.CD012380.pub3.
7
Hydroxyurea (hydroxycarbamide) for sickle cell disease.羟基脲(羟脲)治疗镰状细胞病。
Cochrane Database Syst Rev. 2022 Sep 1;9(9):CD002202. doi: 10.1002/14651858.CD002202.pub3.
8
Laser therapy for retinopathy in sickle cell disease.激光疗法治疗镰状细胞病视网膜病变。
Cochrane Database Syst Rev. 2022 Dec 12;12(12):CD010790. doi: 10.1002/14651858.CD010790.pub3.
9
Low-molecular-weight heparins for managing vaso-occlusive crises in people with sickle cell disease.低分子量肝素用于治疗镰状细胞病患者的血管闭塞性危象。
Cochrane Database Syst Rev. 2015 Dec 18;2015(12):CD010155. doi: 10.1002/14651858.CD010155.pub3.
10
Preoperative blood transfusions for sickle cell disease.镰状细胞病的术前输血
Cochrane Database Syst Rev. 2016 Apr 6;4(4):CD003149. doi: 10.1002/14651858.CD003149.pub3.

本文引用的文献

1
Access to health care for migrants in French Guiana in 2022: a qualitative study of health care system actors.2022 年法属圭亚那移民的医疗保健服务可及性:对医疗保健系统参与者的定性研究。
Front Public Health. 2023 Oct 18;11:1185341. doi: 10.3389/fpubh.2023.1185341. eCollection 2023.
2
Treating Chronic Pain in Sickle Cell Disease - The Need for a Biopsychosocial Model.镰状细胞病慢性疼痛的治疗——生物心理社会模型的必要性
N Engl J Med. 2023 Apr 13;388(15):1349-1351. doi: 10.1056/NEJMp2301143. Epub 2023 Apr 8.
3
Techniques for the Detection of Sickle Cell Disease: A Review.
镰状细胞病的检测技术:综述
Micromachines (Basel). 2021 May 5;12(5):519. doi: 10.3390/mi12050519.
4
Ecology, evolution, and epidemiology of zoonotic and vector-borne infectious diseases in French Guiana: Transdisciplinarity does matter to tackle new emerging threats.法属圭亚那人畜共患病和媒介传播传染病的生态学、进化和流行病学:跨学科研究对于应对新出现的威胁至关重要。
Infect Genet Evol. 2021 Sep;93:104916. doi: 10.1016/j.meegid.2021.104916. Epub 2021 May 15.
5
Building access to care in adult sickle cell disease: defining models of care, essential components, and economic aspects.建立成人镰状细胞病的医疗服务可及性:定义照护模式、基本要素和经济方面。
Blood Adv. 2020 Aug 25;4(16):3804-3813. doi: 10.1182/bloodadvances.2020001743.
6
American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults.美国血液学会2020年镰状细胞病指南:儿童和成人脑血管疾病的预防、诊断和治疗
Blood Adv. 2020 Apr 28;4(8):1554-1588. doi: 10.1182/bloodadvances.2019001142.
7
Reducing Health Care Disparities in Sickle Cell Disease: A Review.减少镰状细胞病中的医疗保健差异:综述。
Public Health Rep. 2019 Nov/Dec;134(6):599-607. doi: 10.1177/0033354919881438. Epub 2019 Oct 10.
8
Air Drep-A Retrospective Study Evaluating the Influence of Weather Conditions and Viral Epidemics on Vaso-Occlusive Crises in Patients with Sickle Cell Disease Living in French Guiana.《空气 Drepanocytes:一项评估法属圭亚那镰状细胞病患者血管阻塞性危象与天气条件和病毒流行之间关系的回顾性研究》
Int J Environ Res Public Health. 2019 Jul 31;16(15):2724. doi: 10.3390/ijerph16152724.
9
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience.当前镰状细胞病患者管理面临的挑战——意大利经验报告。
Orphanet J Rare Dis. 2019 May 30;14(1):120. doi: 10.1186/s13023-019-1099-0.
10
Barriers to Care for Persons With Sickle Cell Disease: The Case Manager's Opportunity to Improve Patient Outcomes.镰状细胞病患者的护理障碍:病例管理员改善患者预后的机会。
Prof Case Manag. 2018 Jul/Aug;23(4):213-219. doi: 10.1097/NCM.0000000000000260.